DLGAP2.md
... ...
@@ -18,15 +18,8 @@ nocite: |
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
21
-|Entity|source |frequency (%)|
22
-|:------:|:----:|:----:|
23
-|BL|GAMBL Exome |2.299 |
24
-|BL|GAMBL Genome |1.158 |
25
-|DLBCL|GAMBL Exome |3.073 |
26
-|DLBCL|GAMBL Genome |2.82 |
27
-|FL|GAMBL Exome |0.86 |
28
-|MCL|GAMBL Genome |1.17 |
29
-
21
+### MCL
22
+[[include:tables/MCL_DLGAP2]]
30 23
31 24
[[include:tables/mermaid_DLGAP2.md]]
32 25
DNAJC6.md
... ...
@@ -18,14 +18,8 @@ nocite: |
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
21
-|Entity|source |frequency (%)|
22
-|:------:|:----:|:----:|
23
-|BL|GAMBL Exome |2.874 |
24
-|BL|GAMBL Genome |0.772 |
25
-|DLBCL|GAMBL Exome |1.509 |
26
-|DLBCL|GAMBL Genome |0.564 |
27
-|FL|GAMBL Exome |0.287 |
28
-
21
+### MCL
22
+[[include:tables/MCL_DNAJC6]]
29 23
30 24
[[include:tables/mermaid_DNAJC6.md]]
31 25
EIF2AK4.md
... ...
@@ -15,18 +15,13 @@ nocite: |
15 15
16 16
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
17 17
18
-|Entity|source |frequency (%)|
19
-|:------:|:-------------:|:-------------:|
20
-|MCL |GAMBL genomes|0.47 |
18
+### MCL
19
+[[include:tables/MCL_EIF2AK4]]
21 20
21
+<!---
22 22
## Mutation pattern and selective pressure estimates
23 23
24
-|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
25
-|:------:|:----:|:---------------------:|:----------------:|:----------------:|
26
-|BL |No |No |1.923 |0 |
27
-|DLBCL |No |No |2.632 |0 |
28
-|FL |No |No |0.000 |0 |
29
-
24
+-->
30 25
31 26
[[include:tables/browser_EIF2AK4.md]]
32 27